Weight Loss: The Data At this time, there arent any published head-to-head obesity trials directly comparing oral semaglutide to orforglipron, says Maria Teresa Anton, MD, a board-certified internal medicine physician who specializes in endocrinology, diabetes, and metabolism with Pritikin Longevity Center in Miami
The APC sent a formal letter to FDA Director Gail Bormel in October 2023, requesting transparency into the process used to make these decisions
5 While these genetic tendencies can complicate weight management, lifestyle changes like regular exercise, lifestyle management, and high-protein diets, can sometimes help counteract these effects, offering a tailored approach to healthier living
Sterility concerns represent another significant risk, particularly for injectable formulations